Nodal/Cripto signaling in fetal male germ cell development: Implications for testicular germ cell tumors

International Journal of Developmental Biology

Volumn 57, Issue 2-4, 2013, Pages 211-219

  Spiller, Cassy M ^a   Bowles, Josephine ^a   Koopman, Peter ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cripto; Germ cell; Nodal; Testicular germ cell tumor

Indexed keywords

PROTEIN NODAL;

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CELL DIFFERENTIATION; CELL MATURATION; FETAL ORIGINS HYPOTHESIS; FETUS (ANATOMY); GERM CELL; GERM CELL TUMOR; HUMAN; MALE; MALIGNANT TRANSFORMATION; NODAL CRIPTO SIGNALING; NONHUMAN; PLURIPOTENT STEM CELL; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TESTIS CANCER; THEORY;

ANIMALS; CELL DIFFERENTIATION; EPIDERMAL GROWTH FACTOR; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GERM CELLS; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; NODAL PROTEIN; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS;

EID: 84880077243     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.130028pk     Document Type: Article

References (108)

1. ADAMI, H.O., BERGSTROM, R., MOHNER, M., ZATONSKI, W., STORM, H., EKBOM, A., TRETLI, S., TEPPO, L., ZIEGLER, H., RAHU, M. et al. (1994). Testicular cancer in nine northern European countries. Int J Cancer 59: 33-38.
2. ALBERIO, R., CROXALL, N. and ALLEGRUCCI, C. (2010). Pig epiblast stem cells depend on activin/nodal signaling for pluripotency and self-renewal. Stem Cells Dev 19: 1627-1636.
3. ALMSTRUP, K., HOEI-HANSEN, C.E., NIELSEN, J.E., WIRKNER, U., ANSORGE, W., SKAKKEBAEK, N.E., RAJPERT-DE MEYTS, E. and LEFFERS, H. (2005). Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br J Cancer 92: 1934-1941.
4. ANDERSSON, O., KORACH-ANDRE, M., REISSMANN, E., IBANEZ, C.F. and BERTOLINO, P. (2008). Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc Natl Acad Sci USA 105: 7252-7256.
5. BARBARO, M., BALSAMO, A., ANDERLID, B.M., MYHRE, A.G., GENNARI, M., NICOLETTI, A., PITTALIS, M.C., OSCARSON, M. and WEDELL, A. (2009). Characterization of deletions at 9p affecting the candidate regions for sex reversal and deletion 9p syndrome by MLPA. Eur J Hum Genet 17: 1439-1447.
6. BARRIOS, F., FILIPPONI, D., PELLEGRINI, M., PARONETTO, M.P., DI SIENA, S., GEREMIA, R., ROSSI, P., DE FELICI, M., JANNINI, E.A. and DOLCI, S. (2010). Opposing effects of retinoic acid and FGF9 on Nanos2 expression and meiotic entry of mouse germ cells. J Cell Sci 123: 871-880.
7. BIANCO, C., ADKINS, H.B., WECHSELBERGER, C., SENO, M., NORMANNO, N., DE LUCA, A., SUN, Y., KHAN, N., KENNEY, N., EBERT, A. et al. (2002). Cripto-1 activates nodal-and ALK4-dependent and-independent signaling pathways in mammary epithelial Cells. Mol Cell Biol 22: 2586-2597.
8. BIANCO, C., STRIZZI, L., EBERT, A., CHANG, C., REHMAN, A., NORMANNO, N., GUEDEZ, L., SALLOUM, R., GINSBURG, E., SUN, Y. et al. (2005). Role of human cripto-1 in tumor angiogenesis. J Natl Cancer Inst 97: 132-141.
9. BIERMANN, K., HEUKAMP, L.C., STEGER, K., ZHOU, H., FRANKE, F.E., GUET-GEMANN, I., SONNACK, V., BREHM, R., BERG, J., BASTIAN, P.J. et al. (2007). Gene expression profiling identifies new biological markers of neoplastic germ cells. Anticancer Res 27: 3091-3100.
10. BIERMANN, K., STOOP, H. and LOOIJENGA, L. (2012). c-KIT protein expression does not discriminate neoplastic from non-neoplastic intratubular germ cells. Histopathology 60: 1017-1019.
11. BOWLES, J., FENG, C.W., SPILLER, C., DAVIDSON, T.L., JACKSON, A. and KOOP-MAN, P. (2010). FGF9 suppresses meiosis and promotes male germ cell fate in mice. Dev Cell 19: 440-449.
12. BOWLES, J., KNIGHT, D., SMITH, C., WILHELM, D., RICHMAN, J., MAMIYA, S., YASHIRO, K., CHAWENGSAKSOPHAK, K., WILSON, M.J., ROSSANT, J. et al. (2006). Retinoid signaling determines germ cell fate in mice. Science 312: 596-600.
13. BRANFORD, W.W. and YOST, H.J. (2002). Lefty-dependent inhibition of Nodal-and Wnt-responsive organizer gene expression is essential for normal gastrulation. Curr Biol 12: 2136-2141.
14. BRONS, I.G., SMITHERS, L.E., TROTTER, M.W., RUGG-GUNN, P., SUN, B., CHUVA DE SOUSA LOPES, S.M., HOWLETT, S.K., CLARKSON, A., AHRLUND-RICHTER, L., PEDERSEN, R.A. et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448: 191-195.
15. CHAMBERS, I., COLBY, D., ROBERTSON, M., NICHOLS, J., LEE, S., TWEEDIE, S. and SMITH, A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
16. CHANG, H., LAU, A.L. and MATZUK, M.M. (2001). Studying TGF-beta superfamily signaling by knockouts and knockins. Mol Cell Endocrinol 180: 39-46.
17. CHEN, C., WARE, S.M., SATO, A., HOUSTON-HAWKINS, D.E., HABAS, R., MAT-ZUK, M.M., SHEN, M.M. and BROWN, C.W. (2006). The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. Development 133: 319-329.
18. CHENG, S.K., OLALE, F., BENNETT, J.T., BRIVANLOU, A.H. and SCHIER, A.F. (2003). EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes Dev 17: 31-36.
19. CHOU, Y.F., CHEN, H.H., EIJPE, M., YABUUCHI, A., CHENOWETH, J.G., TESAR, P., LU, J., MCKAY, R.D. and GEIJSEN, N. (2008). The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell 135: 449-461.
20. CICCODICOLA, A., DONO, R., OBICI, S., SIMEONE, A., ZOLLO, M. and PERSICO, M.G. (1989). Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 8: 1987-1991.
21. DURCOVA-HILLS, G., ADAMS, I.R., BARTON, S.C., SURANI, M.A. and MCLAREN, A. (2006). The role of exogenous fibroblast growth factor-2 on the reprogramming of primordial germ cells into pluripotent stem cells. Stem Cells 24: 1441-1449.
22. DURCOVA-HILLS, G. and SURANI, A. (2008). Reprogramming primordial germ cells (PGC) to embryonic germ (EG) cells. Curr Protoc Stem Cell Biol Chapter 1: Unit1A 3.
23. FELDMAN, B., CONCHA, M.L., SAUDE, L., PARSONS, M.J., ADAMS, R.J., WIL-SON, S.W. and STEMPLE, D.L. (2002). Lefty antagonism of Squint is essential for normal gastrulation. Curr Biol 12: 2129-2135.
24. FERNANDEZ-GARCIA, I., ORTIZ-DE-SOLORZANO, C. and MONTUENGA, L.M. (2008). Telomeres and telomerase in lung cancer. J Thorac Oncol 3: 1085-1088.
25. GIWERCMAN, A., CARLSEN, E., KEIDING, N. and SKAKKEBAEK, N.E. (1993). Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect 101 Suppl 2: 65-71.
26. GRAY, P.C., HARRISON, C.A. and VALE, W. (2003). Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci USA 100: 5193-5198.
27. GRAY, P.C., SHANI, G., AUNG, K., KELBER, J. and VALE, W. (2006). Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol 26: 9268-9278.
28. GRAY, P.C. and VALE, W. (2012). Cripto/GRP78 modulation of the TGF-beta pathway in development and oncogenesis. FEBS Lett 586: 1836-1845.
29. HACKETT, J.A., FELDSER, D.M. and GREIDER, C.W. (2001). Telomere dysfunction increases mutation rate and genomic instability. Cell 106: 275-286.
30. HAMADA, H., MENO, C., WATANABE, D. and SAIJOH, Y. (2002). Establishment of vertebrate left-right asymmetry. Nat Rev Genet 3: 103-113.
31. HEANEY, J.D., LAM, M.Y., MICHELSON, M.V. and NADEAU, J.H. (2008). Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice. Cancer Res 68: 5193-5197.
32. HEIMDAL, K., OLSSON, H., TRETLI, S., FOSSA, S.D., BORRESEN, A.L. and BISHOP, D.T. (1997). A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer 75: 1084-1087.
33. HEMMINKI, K. and LI, X. (2004). Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer 90: 1765-1770.
34. HILSCHER, W. (1974). [Kinetics of prespermatogenesis and spermatogenesis]. Verh Anat Ges 68: 39-62.
35. HOEI-HANSEN, C.E., NIELSEN, J.E., ALMSTRUP, K., HANSEN, M.A., SKAKKE-BAEK, N.E., RAJPERT-DEMEYTS, E. and LEFFERS, H. (2004a). Identification of genes differentially expressed in testes containing carcinoma in situ. Mol Hum Reprod 10: 423-431.
36. HOEI-HANSEN, C.E., NIELSEN, J.E., ALMSTRUP, K., SONNE, S.B., GRAEM, N., SKAKKEBAEK, N.E., LEFFERS, H. and RAJPERT-DE MEYTS, E. (2004b). Transcription factor AP-2gamma is a developmentally regulated marker of tes-ticular carcinoma in situ and germ cell tumors. Clin Cancer Res 10: 8521-8530.
37. HONDA, A., HIROSE, M. and OGURA, A. (2009). Basic FGF and Activin/Nodal but not LIF signaling sustain undifferentiated status of rabbit embryonic stem cells. Exp Cell Res 315: 2033-2042.
38. HONECKER, F., STOOP, H., MAYER, F., BOKEMEYER, C., CASTRILLON, D.H., LAU, Y.F., LOOIJENGA, L.H. and OOSTERHUIS, J.W. (2006). Germ cell lineage differentiation in non-seminomatous germ cell tumours. J Pathol 208: 395-400.
39. HORWICH, A., SHIPLEY, J. and HUDDART, R. (2006). Testicular germ-cell cancer. Lancet 367: 754-765.
40. JACOBSEN, G.K., HENRIKSEN, O.B. and VON DER MAASE, H. (1981). Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: a study of 105 cases. Cancer 47: 2660-2662.
41. JACOBSEN, G.K. and HENRIQUES, U.V. (1992). A fetal testis with intratubular germ cell neoplasia (ITGCN). Mod Pathol 5: 547-549.
42. JAMES, D., LEVINE, A.J., BESSER, D. and HEMMATI-BRIVANLOU, A. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273-1282.
43. JIANG, L.I. and NADEAU, J.H. (2001). 129/Sv mice--a model system for studying germ cell biology and testicular cancer. Mamm Genome 12: 89-94.
44. JORGENSEN, N., RAJPERT-DE MEYTS, E., GRAEM, N., MULLER, J., GIWERC-MAN, A. and SKAKKEBAEK, N.E. (1995). Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 72: 223-231.
45. KEMALADEWI, D.U., DE GORTER, D.J., AARTSMA-RUS, A., VAN OMMEN, G.J., TEN DIJKE, P., T HOEN, P.A. and HOOGAARS, W.M. (2012). Cell-type specific regulation of myostatin signaling. FASEB J 26: 1462-1472.
46. KIMURA, T., SUZUKI, A., FUJITA, Y., YOMOGIDA, K., LOMELI, H., ASADA, N., IKEUCHI, M., NAGY, A., MAK, T.W. and NAKANO, T. (2003). Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130: 1691-1700.
47. KIMURA, T., TOMOOKA, M., YAMANO, N., MURAYAMA, K., MATOBA, S., UME-HARA, H., KANAI, Y. and NAKANO, T. (2008). AKT signaling promotes derivation of embryonic germ cells from primordial germ cells. Development 135: 869-879.
48. KOUBOVA, J., MENKE, D.B., ZHOU, Q., CAPEL, B., GRISWOLD, M.D. and PAGE, D.C. (2006). Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc Natl Acad Sci USA 103: 2474-2479.
49. KRENTZ, A.D., MURPHY, M.W., KIM, S., COOK, M.S., CAPEL, B., ZHU, R., MATIN, A., SARVER, A.L., PARKER, K.L., GRISWOLD, M.D. et al. (2009). The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc Natl Acad Sci USA 106: 22323-22328.
50. KRISTENSEN, D.M., SONNE, S.B., OTTESEN, A.M., PERRETT, R.M., NIELSEN, J.E., ALMSTRUP, K., SKAKKEBAEK, N.E., LEFFERS, H. and RAJPERT-DE MEYTS, E. (2008). Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. Mol Cell Endocrinol 288: 111-118.
51. LABOSKY, P.A., BARLOW, D.P. and HOGAN, B.L. (1994). Mouse embryonic germ (EG) cell lines: transmission through the germline and differences in the meth-ylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 120: 3197-3204.
52. LI, Y., TABATABAI, Z.L., LEE, T.L., HATAKEYAMA, S., OHYAMA, C., CHAN, W.Y., LOOIJENGA, L.H. and LAU, Y.F. (2007). The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum Pathol 38: 1470-1481.
53. LIGUORI, G.L., BORGES, A.C., D'ANDREA, D., LIGUORO, A., GONCALVES, L., SALGUEIRO, A.M., PERSICO, M.G. and BELO, J.A. (2008). Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo. Dev Biol 315: 280-289.
54. LINKE, J., LOY, V. and DIECKMANN, K.P. (2005). Prevalence of testicular intraepi-thelial neoplasia in healthy males. J Urol 173: 1577-1579.
55. LIVADAS, S., MAVROU, A., SOFOCLEOUS, C., VAN VLIET-CONSTANTINIDOU, C., DRACOPOULOU, M. and DACOU-VOUTETAKIS, C. (2003). Gonadoblastoma in a patient with del(9)(p22) and sex reversal: report of a case and review of the literature. Cancer Genet Cytogenet 143: 174-177.
56. LOH, Y.H., WU, Q., CHEW, J.L., VEGA, V.B., ZHANG, W., CHEN, X., BOURQUE, G., GEORGE, J., LEONG, B., LIU, J. et al. (2006). The Oct4 and Nanog tran-scription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440.
57. LOOIJENGA, L.H., DE LEEUW, H., VAN OORSCHOT, M., VAN GURP, R.J., STOOP, H., GILLIS, A.J., DE GOUVEIA BRAZAO, C.A., WEBER, R.F., KIRKELS, W.J., VAN DIJK, T. et al. (2003). Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 63: 7674-7678.
58. LOOIJENGA, L.H., OLIE, R.A., VAN DER GAAG, I., VAN SLUIJS, F.J., MATOSKA, J., PLOEM-ZAAIJER, J., KNEPFLE, C. and OOSTERHUIS, J.W. (1994). Semi-nomas of the canine testis. Counterpart of spermatocytic seminoma of men? Lab Invest 71: 490-496.
59. LOWE, L.A., YAMADA, S. and KUEHN, M.R. (2001). Genetic dissection of nodal function in patterning the mouse embryo. Development 128: 1831-1843.
60. MANIVEL, J.C., JESSURUN, J., WICK, M.R. and DEHNER, L.P. (1987). Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms. Am J Surg Pathol 11: 21-29.
61. MATSUI, Y. and TOKITAKE, Y. (2009). Primordial germ cells contain subpopulations that have greater ability to develop into pluripotential stem cells. Dev Growth Differ 51: 657-667.
62. MATSUI, Y., ZSEBO, K. and HOGAN, B.L. (1992). Derivation of pluripotential em-bryonic stem cells from murine primordial germ cells in culture. Cell 70: 841-847.
63. MCGLYNN, K.A., DEVESA, S.S., GRAUBARD, B.I. and CASTLE, P.E. (2005). In-creasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 23: 5757-5761.
64. MCLAREN, A. and SOUTHEE, D. (1997). Entry of mouse embryonic germ cells into meiosis. Dev Biol 187: 107-113.
65. MENDIS, S.H., MEACHEM, S.J., SARRAJ, M.A. and LOVELAND, K.L. (2010). Activin A Balances Sertoli and Germ Cell Proliferation in the Fetal Mouse Testis. Biol Reprod.
66. MENO, C., GRITSMAN, K., OHISHI, S., OHFUJI, Y., HECKSCHER, E., MOCHIDA, K., SHIMONO, A., KONDOH, H., TALBOT, W.S., ROBERTSON, E.J. et al. (1999). Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation. Mol Cell 4: 287-298.
67. MITSUI, K., TOKUZAWA, Y., ITOH, H., SEGAWA, K., MURAKAMI, M., TAKAHASHI, K., MARUYAMA, M., MAEDA, M. and YAMANAKA, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
68. MURTY, V.V., HOULDSWORTH, J., BALDWIN, S., REUTER, V., HUNZIKER, W., BESMER, P., BOSL, G. and CHAGANTI, R.S. (1992). Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proc Natl Acad Sci USA 89: 11006-11010.
69. NIELSEN, H., NIELSEN, M. and SKAKKEBAEK, N.E. (1974). The fine structure of possible carcinoma-in-situ in the seminiferous tubules in the testis of four infertile men. Acta Pathol Microbiol Scand A 82: 235-248.
70. NISHIMUNE, Y., HANEJI, T. and KITAMURA, Y. (1980). The effects of steel mutation on testicular germ cell differentiation. J Cell Physiol 105: 137-141.
71. OOSTERHUIS, J.W., STOOP, H., HONECKER, F. and LOOIJENGA, L.H. (2007). Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl 30: 256-263; discussion 263-254.
72. PAPAGEORGIOU, I., NICHOLLS, P.K., WANG, F., LACKMANN, M., MAKANJI, Y., SALAMONSEN, L.A., ROBERTSON, D.M. and HARRISON, C.A. (2009). Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Reprod Biol Endocrinol 7: 122.
73. POSTOVIT, L.M., MARGARYAN, N.V., SEFTOR, E.A., KIRSCHMANN, D.A., LIPAVSKY, A., WHEATON, W.W., ABBOTT, D.E., SEFTOR, R.E. and HENDRIX, M.J. (2008). Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 105: 4329-4334.
74. RAJPERT-DE-MEYTS, E. (2006). Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12: 303-323.
75. RAJPERT-DE MEYTS, E., BARTKOVA, J., SAMSON, M., HOEI-HANSEN, C.E., FRYDELUND-LARSEN, L., BARTEK, J. and SKAKKEBAEK, N.E. (2003). The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 111: 267-278; discussion 278-269.
76. RAJPERT-DE MEYTS, E. and SKAKKEBAEK, N.E. (1993). The possible role of sex hormones in the development of testicular cancer. Eur Urol 23: 54-59; discus-sion 60-51.
77. RAJPERT-DE MEYTS, E. and SKAKKEBAEK, N.E. (1994). Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 17: 85-92.
78. RESNICK, J.L., BIXLER, L.S., CHENG, L. and DONOVAN, P.J. (1992). Long-term proliferation of mouse primordial germ cells in culture. Nature 359: 550-551.
79. RICHIARDI, L., BELLOCCO, R., ADAMI, H.O., TORRANG, A., BARLOW, L., HAKU-LINEN, T., RAHU, M., STENGREVICS, A., STORM, H., TRETLI, S. et al. (2004). Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13: 2157-2166.
80. ROSKOSKI, R., JR. (2005). Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor. Biochem Biophys Res Commun 337: 1-13.
81. SASAKI, A., TAKETOMI, T., KATO, R., SAEKI, K., NONAMI, A., SASAKI, M., KURI-YAMA, M., SAITO, N., SHIBUYA, M. and YOSHIMURA, A. (2003). Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Cell Cycle 2: 281-282.
82. SATGE, D., JACOBSEN, G.K., CESSOT, F., RAFFI, F. and VEKEMANS, M. (1996). A fetus with Down syndrome and intratubular germ cell neoplasia. Pediatr Pathol Lab Med 16: 107-112.
83. SCHIER, A.F. (2009). Nodal morphogens. Cold Spring Harb Perspect Biol 1: a003459.
84. SCHIER, A.F. and SHEN, M.M. (2000). Nodal signalling in vertebrate development. Nature 403: 385-389.
85. SCHRADER, M., BURGER, A.M., MULLER, M., KRAUSE, H., STRAUB, B., SMITH, G.L., NEWLANDS, E.S. and MILLER, K. (2002). Quantification of human telom-erase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR. Oncol Rep 9: 1097-1105.
86. SHAH, M.N., DEVESA, S.S., ZHU, K. and MCGLYNN, K.A. (2007). Trends in tes-ticular germ cell tumours by ethnic group in the United States. Int J Androl 30: 206-213; discussion 213-204.
87. SHEN, M.M. (2007). Nodal signaling: developmental roles and regulation. Develop-ment 134: 1023-1034.
88. SIGG, C. and HEDINGER, C. (1984). Atypical germ cells of the testis. Comparative ultrastructural and immunohistochemical investigations. Virchows Arch A Pathol Anat Histopathol 402: 439-450.
89. SKAKKEBAEK, N.E. (1972). Possible carcinoma-in-situ of the testis. Lancet 2: 516-517.
90. SKAKKEBAEK, N.E., BERTHELSEN, J.G., GIWERCMAN, A. and MULLER, J. (1987). Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10: 19-28.
91. SMITH, C.A., MCCLIVE, P.J., WESTERN, P.S., REED, K.J. and SINCLAIR, A.H. (1999). Conservation of a sex-determining gene. Nature 402: 601-602.
92. SONNE, S.B., ALMSTRUP, K., DALGAARD, M., JUNCKER, A.S., EDSGARD, D., RUBAN, L., HARRISON, N.J., SCHWAGER, C., ABDOLLAHI, A., HUBER, P.E. et al. (2009). Analysis of gene expression profiles of microdissected cell popula-tions indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 69: 5241-5250.
93. SOUQUET, B., TOURPIN, S., MESSIAEN, S., MOISON, D., HABERT, R. and LIVERA, G. (2012). Nodal Signaling Regulates the Entry into Meiosis in Fetal Germ Cells. Endocrinology 153(5):2466-2473.
94. SPILLER, C.M., FENG, C.W., JACKSON, A., GILLIS, A.J.M., ROLLAND, A.D., LOOIJENGA, L.H.J., KOOPMAN, P. and BOWLES, J. (2012). Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development 139(22):4123-4132.
95. STEVENS, L.C. (1967). Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst 38: 549-552.
96. STEVENS, L.C. (1984). Spontaneous and experimentally induced testicular teratomas in mice. Cell Differ 15: 69-74.
97. SWERDLOW, A.J., DOS SANTOS SILVA, I., REID, A., QIAO, Z., BREWSTER, D.H. and ARRUNDALE, J. (1998). Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer 77 Suppl 3: 1-54.
98. TESAR, P.J., CHENOWETH, J.G., BROOK, F.A., DAVIES, T.J., EVANS, E.P., MACK, D.L., GARDNER, R.L. and MCKAY, R.D. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448: 196-199.
99. TURNBULL, C. and RAHMAN, N. (2011). Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour. Int J Androl 34: e86-96; discussion e96-87.
100. ULBRIGHT, T.M. (1999). Testis risk and prognostic factors. The pathologist's perspec-tive. Urol Clin North Am 26: 611-626.
101. VALLIER, L., REYNOLDS, D. and PEDERSEN, R.A. (2004). Nodal inhibits differentia-tion of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 275: 403-421.
102. VAN DE GEIJN, G.J., HERSMUS, R. and LOOIJENGA, L.H. (2009). Recent de-velopments in testicular germ cell tumor research. Birth Defects Res C Embryo Today 87: 96-113.
103. VISFELDT, J., JORGENSEN, N., MULLER, J., MOLLER, H. and SKAKKEBAEK, N.E. (1994). Testicular germ cell tumours of childhood in Denmark, 1943-1989: incidence and evaluation of histology using immunohistochemical techniques. J Pathol 174: 39-47.
104. VON DER MAASE, H., RORTH, M., WALBOM-JORGENSEN, S., SORENSEN, B.L., CHRISTOPHERSEN, I.S., HALD, T., JACOBSEN, G.K., BERTHELSEN, J.G. and SKAKKEBAEK, N.E. (1986). Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 293: 1398-1401.
105. WATANABE, K., MEYER, M.J., STRIZZI, L., LEE, J.M., GONZALES, M., BIANCO, C., NAGAOKA, T., FARID, S.S., MARGARYAN, N., HENDRIX, M.J. et al. (2010). Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells 28: 1303-1314.
106. WECHSELBERGER, C., STRIZZI, L., KENNEY, N., HIROTA, M., SUN, Y., EBERT, A., OROZCO, O., BIANCO, C., KHAN, N.I., WALLACE-JONES, B. et al. (2005). Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene 24: 4094-4105.
107. YAN, W., SAMSON, M., JEGOU, B. and TOPPARI, J. (2000). Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. Mol Endocrinol 14: 682-699.
108. YOUNGREN, K.K., COVENEY, D., PENG, X., BHATTACHARYA, C., SCHMIDT, L.S., NICKERSON, M.L., LAMB, B.T., DENG, J.M., BEHRINGER, R.R., CAPEL, B. et al. (2005). The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 435: 360-364.s